^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CBM-C20.1

    i
    Other names: CART-20, anti-CD20 chimeric antigen receptor T cell therapy, anti-CD20 CART cells, CAR-CD20 T cell therapy, CART20, CBM-C20.1
    Associations
    News
    Trials
    Company:
    AbelZeta Pharma
    Drug class:
    CD20-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials